138 related articles for article (PubMed ID: 8342555)
1. Heterogeneous proliferative effect of tumor necrosis factor-alpha and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemia.
Alvarez-Mon M; Garcia-Suarez J; Prieto A; Manzano L; Reyes E; Lorences C; Peraile G; Jorda J; Durantez A
Am J Hematol; 1993 Jun; 43(2):81-5. PubMed ID: 8342555
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.
Aderka D; Maor Y; Novick D; Engelmann H; Kahn Y; Levo Y; Wallach D; Revel M
Blood; 1993 Apr; 81(8):2076-84. PubMed ID: 8386026
[TBL] [Abstract][Full Text] [Related]
6. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.
Digel W; Stefanic M; Schöniger W; Buck C; Raghavachar A; Frickhofen N; Heimpel H; Porzsolt F
Blood; 1989 Apr; 73(5):1242-6. PubMed ID: 2539214
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
Jelinek DF; Lipsky PE
J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
[TBL] [Abstract][Full Text] [Related]
9. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
Karray S; Emilie D; Galanaud P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
[TBL] [Abstract][Full Text] [Related]
12. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells.
Kulmburg P; Radke M; Digel W
Leukemia; 1998 Apr; 12(4):493-8. PubMed ID: 9557606
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
15. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.
Aguilar-Santelises M; Mellstedt H; Jondal M
Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606
[TBL] [Abstract][Full Text] [Related]
16. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
Nerl C; Janssen O; Kabelitz D
Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
[TBL] [Abstract][Full Text] [Related]
17. Abnormal response to IL-5 in B-cell chronic lymphocytic leukemia.
Hayes TG; Tan XL; Moseley AB; Huston MM; Huston DP
Leuk Res; 1993 Sep; 17(9):777-83. PubMed ID: 8371578
[TBL] [Abstract][Full Text] [Related]
18. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
20. Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia.
Berrebi A; Shtalrid M; Klepfish A; Bassous L; Kushnir M; Shulman L; Vorst E; Hahn T
Leukemia; 1994 Dec; 8(12):2214-6. PubMed ID: 7808009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
